Did the COVID-19 pandemic increase drunkness among people with a history of alcohol use disorder?

How COVID-19-related stressors altered drunkenness frequency.

A startup backed by Nobel winner David Baker takes an AI twist on antibodies

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 31, 2024

EU committee confirms negative opinion for Amylyx ALS drug, rejecting company appeal

The European Medicines Agency rejected on Friday an appeal from Amylyx Pharmaceuticals to reconsider a negative review opinion for its ALS drug Relyvrio, further dimming

October 14, 2023

Discovery of over 1,000 undetected proteins in metabolite samples

Van Andel Institute scientists have identified more than 1,000 previously undetected proteins in common metabolite samples, which persist despite extraction methods designed to weed them

July 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.